These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7604821)

  • 1. Skin necrosis after subcutaneous low molecular weight heparin injection.
    Real E; Grau E; Rubio M; Torrecilla T
    Am J Hematol; 1995 Jul; 49(3):253-4. PubMed ID: 7604821
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin necrosis at the injection site induced by low-molecular-weight heparin: case report and review.
    Santamaría A; Romaní J; Souto JC; López A; Mateo J; Fontcuberta J
    Dermatology; 1998; 196(2):264-5. PubMed ID: 9568422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight subcutaneous heparin-induced skin necrosis.
    Montserrat I; Lopez D; Zuazu-Jausoro I; Perez M; de Moragas JM; Fontcuberta J
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):751-2. PubMed ID: 1966800
    [No Abstract]   [Full Text] [Related]  

  • 4. Low molecular weight heparin-induced skin necrosis occurring distant from injection sites and without thrombocytopenia.
    Tietge UJ; Schmidt HH; Jäckel E; Trautwein C; Manns MP
    J Intern Med; 1998 Apr; 243(4):313-5. PubMed ID: 9627146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum-like skin changes after subcutaneous administration of low molecular weight heparin.
    Sobieszczańska M; Tubek S; Kura I
    Hum Vaccin Immunother; 2014; 10(4):968-9. PubMed ID: 24441397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unfractionated standard heparin versus low molecular weight heparins].
    Schrader J; Haas S
    Internist (Berl); 1993 Nov; 34(11):1053-7; discussion 1058. PubMed ID: 8282491
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH).
    Samama MM
    Adv Exp Med Biol; 1992; 313():275-81. PubMed ID: 1332441
    [No Abstract]   [Full Text] [Related]  

  • 8. Skin necrosis secondary to low-molecular weight heparin in a patient with antiphospholipid antibody syndrome.
    Gibson GE; Gibson LE; Drage LA; Garrett CR; Gertz MA
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 2):855-9. PubMed ID: 9366852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
    Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous or subcutaneous heparin. What is better in deep venous thrombosis?].
    MMW Fortschr Med; 2002 Jun; 144(26):55. PubMed ID: 12154485
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel subcutaneous low-molecular-weight heparin injection technique to reduce post-injection bruising.
    Jueakaew S; Piancharoensin R; Pinkesorn N; Thippayarom S; Sermsathanasawadi N
    Phlebology; 2019 Jul; 34(6):399-405. PubMed ID: 30453827
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of thromboses with low molecular weight heparins].
    Haas S
    Z Kardiol; 1993; 82 Suppl 2():77-80. PubMed ID: 8392238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparin-induced thrombocytopenia and skin necrosis distant from injection sites.
    Balestra B; Quadri P; Dermarmels Biasiutti F; Furlan M; Lämmle B
    Eur J Haematol; 1994 Jul; 53(1):61-3. PubMed ID: 8062903
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-molecular-weight heparin-induced skin necrosis: about 2 cases.
    Yombi JC; Belkhir L; De Baere T; Dubuc JE; Hainaut P
    Acta Clin Belg; 2009; 64(3):228-30. PubMed ID: 19670563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: a quasi-experimental case-crossover study.
    Palese A; Aidone E; Dante A; Pea F
    J Cardiovasc Nurs; 2013; 28(5):473-82. PubMed ID: 22760174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.
    Koch P; Münssinger T; Rupp-John C; Uhl K
    J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux.
    Maetzke J; Hinrichs R; Schneider LA; Scharffetter-Kochanek K
    Allergy; 2005 Mar; 60(3):413-5. PubMed ID: 15679737
    [No Abstract]   [Full Text] [Related]  

  • 18. Generalised cutaneous necrosis: a complication of low-molecular-weight heparin.
    Patel GK; Knight AG
    Int Wound J; 2005 Sep; 2(3):267-70. PubMed ID: 16618332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT).
    Bratt G; Aberg W; Johansson M; Törnebohm E; Granqvist S; Lockner D
    Thromb Haemost; 1990 Dec; 64(4):506-10. PubMed ID: 1964751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed hypersensitivity at the injection sites of a low-molecular-weight heparin.
    Moreau A; Dompmartin A; Esnault P; Michel M; Leroy D
    Contact Dermatitis; 1996 Jan; 34(1):31-4. PubMed ID: 8789222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.